KCAS Bio is excited to announce our attendance at AusBiotech 2024 in Melbourne, Australia. As a leader in bioanalytical services, we are committed to supporting the growth and innovation of the biotech industry. This premier event offers a unique platform to engage with industry experts, innovators, and decision-makers, all working…

In the dynamic field of biotherapeutics, understanding and managing anti-drug antibodies (ADAs) is critical for the success of drug development programs. ADAs can potentially neutralize the efficacy of biotherapeutic drugs, making it essential to have robust testing methodologies in place from the preclinical to clinical stages. KCAS Bio is excited…

In the fast-paced world of drug development, the ability to produce accurate and reproducible data is paramount. That’s why staying updated with the latest best practices in flow cytometry is crucial. Our webinar, “Evolving Best Practices: Considerations for Conventional and Spectral Flow,” dives deep into the rapidly advancing field of…

In the rapidly advancing world of flow cytometry, staying ahead of the curve is essential for driving impactful research and drug development. Our panel discussion, “Evolving Best Practices in High-Complexity Flow Cytometry,” sheds light on the latest developments that can enhance and accelerate your research efforts. Flow cytometry has long…

KCAS Bio is thrilled to participate in the 16th Annual Immunogenicity and Bioassay Summit, taking place from October 15-18, 2024, at The Watergate Hotel in Washington, D.C. This summit is a premier event that brings together top industry, academia, and regulatory authorities to discuss the latest advancements and challenges in…

KCAS Bio is excited to announce our attendance at the Applied Pharmaceutical Analysis (APA) 2024 conference, taking place from October 7-9 at Bristol Myers Squibb in Cambridge, MA. This event gathers experts from across the pharmaceutical industry to discuss the latest advancements in bioanalysis, drug development, and regulatory practices. Exploring…

The world of medicine relies heavily on innovation, and Contract Research Organizations (CROs) are key players behind the scenes. But what exactly is a CRO, and why are these organizations so crucial to the development of new therapies and medical advancements? Let’s explore what CROs do and why they’re vital…

KCAS Bio is excited to announce our participation in the annual congress of the French Society for Toxicology, taking place on November 14-15 at the Lyon Convention Center. This landmark event, celebrating the 50th anniversary of the French Society of Toxicology will focus on “Evolutions, Innovations, and New Trends in…

2020 was an odd year for everyone. In what felt like just days, it seemed everything had changed and the rules were being rewritten almost daily about how we would all be engaging with one another. We went from racking up travel, hotel stays and airmiles while visiting our customers…

KCAS Bio is happy to announce our participation in the 17th EBF Open Symposium, taking place in Barcelona, Spain, from November 20-22, 2024. This prestigious event is a cornerstone for professionals in bioanalysis, offering a platform to share cutting-edge research, innovative methodologies, and industry best practices. We are thrilled to…

KCAS Bio is excited to announce our participation in the AAPS 2024 PHARMSCI 360 conference, taking place in Salt Lake City, Utah, from October 20-23. This premier event brings together scientists, researchers, and industry leaders from around the globe to discuss the latest advancements in pharmaceutical sciences. We are thrilled…

Georges Köhler and César Milstein: The birth of monoclonal antibodies They discovered the technique for monoclonal antibody production. They won the Nobel Prize in Physiology or Medicine in 1984. They directly led to the development of antibody-based therapies for a vast array of health conditions. Since their initial invention…